March 8 (Bloomberg) -- Johnson & Johnson’s Animas unit recalled leaking insulin cartridges, saying they may cause pumps to deliver too little medicine to patients.
Animas notified patients of the problem in a Feb. 24 letter, saying the recall affects 2-milliliter cartridges shipped between Nov. 30 and Jan. 4. A leaking cartridge may prevent an insulin pump from sounding an alert over blockages in the device’s infusion system, the letter said.
Animas said it learned of “several cases” of leaking insulin and that any faulty cartridges would be replaced free of charge. The recall covers five lots of cartridges.
J&J is based in New Brunswick, New Jersey.
To contact the reporter on this story: Alex Nussbaum in New York email@example.com.
To contact the editor responsible for this story: Reg Gale at Rgale5@bloomberg.net